• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性胰上淋巴结的晚期胃癌预后不良。

Poor prognosis of advanced gastric cancer with metastatic suprapancreatic lymph nodes.

机构信息

Department of Gastroenterological Surgery, Oita University Faculty of Medicine, Yufu, Oita, Japan.

出版信息

Ann Surg Oncol. 2013 Jul;20(7):2290-5. doi: 10.1245/s10434-012-2839-8. Epub 2013 Jan 9.

DOI:10.1245/s10434-012-2839-8
PMID:23299769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3675275/
Abstract

BACKGROUND

Whether gastrectomy with D2 lymphadenectomy improves survival of patients with advanced gastric cancer (AGC) remains controversial. Few studies have described the pathological features of AGC with metastatic suprapancreatic lymph nodes (LN), which are the target of D2 lymphadenectomy. This study therefore aims to clarify the prognosis and clinical pathological features including the number and location of metastatic LN in AGC with metastatic suprapancreatic LN.

METHODS

406 patients with AGC, who underwent gastrectomy with D2 lymphadenectomy from 1982 to 2007 at Oita University, were reviewed retrospectively with regard to presence or absence of metastatic suprapancreatic LN. The pathological factors associated with AGC with metastatic suprapancreatic LN were examined by univariate and multivariate analysis.

RESULTS

Of 362 patients with AGC, 78 had suprapancreatic LN metastasis (21.5 %), differing significantly in terms of presence of vascular invasion and having a larger number of metastatic perigastric LN in comparison with only metastatic perigastric LN on univariate analysis. According to multivariate analysis, they were associated with presence of vascular invasion and a large number of total metastatic LN (more than two; N2≤). The overall 5-year survival rate of the AGC with perigastric LN metastasis (station 1-7) group was 37.9 % and of the AGC with suprapancreatic LN metastasis group was 12.8 %. There were significant differences in each group (P < 0.05).

CONCLUSIONS

Patients with AGC with metastatic suprapancreatic LN had a large number of total metastatic LN and poor prognosis, suggesting that it may be a systemic disease.

摘要

背景

胃切除术加 D2 淋巴结清扫术是否能提高晚期胃癌(AGC)患者的生存率仍存在争议。很少有研究描述过具有转移性胰上淋巴结(LN)的 AGC 的病理特征,而这些淋巴结是 D2 淋巴结清扫术的目标。因此,本研究旨在阐明具有转移性胰上 LN 的 AGC 的预后和临床病理特征,包括转移性 LN 的数量和位置。

方法

回顾性分析了 1982 年至 2007 年在大分大学接受胃切除术加 D2 淋巴结清扫术的 406 例 AGC 患者,以确定是否存在转移性胰上 LN。通过单因素和多因素分析,研究了与具有转移性胰上 LN 的 AGC 相关的病理因素。

结果

在 362 例 AGC 患者中,78 例有胰上 LN 转移(21.5%),与仅具有胃周 LN 转移(站 1-7)的患者相比,在单因素分析中,这些患者具有血管侵犯和更多的胃周转移性 LN。根据多因素分析,它们与血管侵犯和大量总转移性 LN(超过 2 个;N2≤)的存在相关。仅具有胃周 LN 转移(站 1-7)的 AGC 患者的 5 年总生存率为 37.9%,而具有胰上 LN 转移的 AGC 患者的 5 年总生存率为 12.8%。两组间差异有统计学意义(P < 0.05)。

结论

具有转移性胰上 LN 的 AGC 患者具有大量的总转移性 LN 和较差的预后,表明其可能是一种全身性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/3675275/4b18db2ebe04/10434_2012_2839_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/3675275/4b18db2ebe04/10434_2012_2839_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/3675275/4b18db2ebe04/10434_2012_2839_Fig1_HTML.jpg

相似文献

1
Poor prognosis of advanced gastric cancer with metastatic suprapancreatic lymph nodes.转移性胰上淋巴结的晚期胃癌预后不良。
Ann Surg Oncol. 2013 Jul;20(7):2290-5. doi: 10.1245/s10434-012-2839-8. Epub 2013 Jan 9.
2
Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.胃癌患者胃左动脉旁淋巴结的生存预后及临床病理特征:对D2淋巴结清扫术的意义
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14365-73. eCollection 2015.
3
Why the Proximal Splenic Artery Approach is the Ideal Approach for Laparoscopic Suprapancreatic Lymph Node Dissection in Advanced Gastric Cancer? A Large-Scale Vascular-Anatomical-Based Study.为何脾动脉近端入路是进展期胃癌腹腔镜胰上淋巴结清扫的理想入路?一项基于大规模血管解剖的研究。
Medicine (Baltimore). 2015 May;94(18):e832. doi: 10.1097/MD.0000000000000832.
4
Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance.腹腔镜全胃切除术治疗中上段进展期胃癌:基于淋巴结清扫不足的分析。
Gastric Cancer. 2020 Jan;23(1):184-194. doi: 10.1007/s10120-019-00986-0. Epub 2019 Jul 12.
5
Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer.应用吲哚菁绿荧光成像和组织标记染料对临床进展期胃癌胃周淋巴管网的研究。
Eur J Surg Oncol. 2022 Feb;48(2):411-417. doi: 10.1016/j.ejso.2021.08.029. Epub 2021 Aug 27.
6
Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.Ⅱ期胃癌中淋巴管和/或血管侵犯的影响。
World J Gastroenterol. 2012 Jul 21;18(27):3610-6. doi: 10.3748/wjg.v18.i27.3610.
7
Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.淋巴结阴性的进展期胃癌的预后因素和复发模式。
Eur J Surg Oncol. 2013 Feb;39(2):136-40. doi: 10.1016/j.ejso.2012.10.008. Epub 2012 Nov 11.
8
Long term oncological outcome of patients with grossly early gastric cancer-mimicking advanced gastric cancer.大体早期胃癌样进展期胃癌患者的长期肿瘤学结局。
Eur J Surg Oncol. 2020 Jul;46(7):1262-1268. doi: 10.1016/j.ejso.2020.03.205. Epub 2020 Mar 18.
9
The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study.III 期胃癌患者 D2 清扫术后预后不良主要与淋巴结转移相关,尤其是第 12aLN 转移:巢式病例对照研究。
Oncol Res Treat. 2021;44(6):313-321. doi: 10.1159/000512934. Epub 2021 May 4.
10
Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.标准D2和扩大D2淋巴结清扫的远端次全胃切除术对局部进展期胃癌的预后意义
Sci Rep. 2015 Nov 25;5:17273. doi: 10.1038/srep17273.

引用本文的文献

1
Occult gastric carcinoma with microsatellite instability diagnosed 10 years after excision of metastatic lymph node: a case report.转移性淋巴结切除术后10年诊断为微卫星不稳定的隐匿性胃癌:一例报告
Surg Case Rep. 2024 Aug 9;10(1):185. doi: 10.1186/s40792-024-01988-6.
2
Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer.HOXC6mRNA 表达增加是胃癌的一种新型生物标志物。
PLoS One. 2020 Aug 3;15(8):e0236811. doi: 10.1371/journal.pone.0236811. eCollection 2020.
3
Protein expression profiles and clinicopathologic characteristics associate with gastric cancer survival.

本文引用的文献

1
Japanese gastric cancer treatment guidelines 2010 (ver. 3).《日本胃癌治疗指南2010(第3版)》
Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4.
2
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.胃癌的外科治疗:随机全国性荷兰 D1D2 试验的 15 年随访结果。
Lancet Oncol. 2010 May;11(5):439-49. doi: 10.1016/S1470-2045(10)70070-X. Epub 2010 Apr 19.
3
Recurrence after curative resection of early gastric cancer.早期胃癌根治性切除术后复发。
蛋白表达谱与临床病理特征与胃癌生存相关。
Biol Res. 2019 Aug 9;52(1):42. doi: 10.1186/s40659-019-0249-0.
4
Prognostic significance of suprapancreatic lymph nodes and its implication on D2 dissection.胰上淋巴结的预后意义及其对D2淋巴结清扫的影响
Medicine (Baltimore). 2018 Jun;97(25):e11092. doi: 10.1097/MD.0000000000011092.
5
Silencing of peroxiredoxin II by promoter methylation is necessary for the survival and migration of gastric cancer cells.启动子甲基化沉默过氧化物还原酶 II 是胃癌细胞存活和迁移所必需的。
Exp Mol Med. 2018 Feb 9;50(2):e443. doi: 10.1038/emm.2017.267.
6
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.利用汇总患者数据对二线雷莫西尤单抗两项III期研究(REGARD和RAINBOW)中胃癌总生存期的预后因素分析
J Gastric Cancer. 2017 Jun;17(2):132-144. doi: 10.5230/jgc.2017.17.e16. Epub 2017 Jun 16.
7
Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China.中国西北地区进展期胃癌患者脾门淋巴结转移的相关危险因素
Int J Clin Exp Med. 2015 Nov 15;8(11):21358-64. eCollection 2015.
8
Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.纤连蛋白-1的低表达与胃癌的不良预后相关。
Tumour Biol. 2016 Jul;37(7):9399-410. doi: 10.1007/s13277-015-4537-1. Epub 2016 Jan 16.
9
Prognostic value of tumor size in patients with remnant gastric cancer: is the seventh UICC stage sufficient for predicting prognosis?残胃癌患者肿瘤大小的预后价值:国际抗癌联盟(UICC)第七版分期对预后预测是否足够?
PLoS One. 2014 Dec 30;9(12):e115776. doi: 10.1371/journal.pone.0115776. eCollection 2014.
10
Silencing Bmi-1 enhances the senescence and decreases the metastasis of human gastric cancer cells.沉默 Bmi-1 增强人胃癌细胞衰老和降低转移。
World J Gastroenterol. 2013 Dec 14;19(46):8764-9. doi: 10.3748/wjg.v19.i46.8764.
Ann Surg Oncol. 2010 Feb;17(2):448-54. doi: 10.1245/s10434-009-0772-2. Epub 2009 Nov 11.
4
Sentinel node mapping and skip metastases in patients with early gastric cancer.早期胃癌患者的前哨淋巴结定位与跳跃转移
Ann Surg Oncol. 2009 Mar;16(3):603-8. doi: 10.1245/s10434-008-0283-6. Epub 2009 Jan 6.
5
Multivariate prognostic study on large gastric cancer.大型胃癌的多因素预后研究
J Surg Oncol. 2007 Jul 1;96(1):14-8. doi: 10.1002/jso.20631.
6
Nodal dissection for patients with gastric cancer: a randomised controlled trial.胃癌患者的淋巴结清扫:一项随机对照试验。
Lancet Oncol. 2006 Apr;7(4):309-15. doi: 10.1016/S1470-2045(06)70623-4.
7
Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.胃癌腺癌扩大与有限淋巴结清扫技术
Cochrane Database Syst Rev. 2004 Oct 18(4):CD001964. doi: 10.1002/14651858.CD001964.pub2.
8
Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.一项评估胃癌D2胃切除术的多中心II期研究的生存结果。
Br J Cancer. 2004 May 4;90(9):1727-32. doi: 10.1038/sj.bjc.6601761.
9
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.胃癌扩大淋巴结清扫术:谁可能获益?荷兰胃癌研究组随机试验的最终结果
J Clin Oncol. 2004 Jun 1;22(11):2069-77. doi: 10.1200/JCO.2004.08.026. Epub 2004 Apr 13.
10
Evaluation of colloid size for sentinel nodes detection using radioisotope in early gastric cancer.使用放射性同位素评估早期胃癌前哨淋巴结检测中的胶体大小。
Cancer Lett. 2003 Oct 8;200(1):19-24. doi: 10.1016/s0304-3835(03)00389-6.